Poor and protracted myelination as a contributory factor to neurodegenerative disorders

Neurobiology of Aging

Volumn 25, Issue 1, 2004, Pages 19-23

  Braak, Heiko ^a   Del Tredici, Kelly ^a  

^a Department of Clinical Neuroanatomy ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; BRAIN CORTEX; DEGENERATIVE DISEASE; DISEASE COURSE; DISEASE PREDISPOSITION; GRAY MATTER; HUMAN; LEWY BODY; MYELINATED NERVE; MYELINATION; NEOCORTEX; NERVE INJURY; NERVE PROJECTION; NOTE; OLIGODENDROGLIA; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; RISK FACTOR;

EID: 0346850964     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.04.001     Document Type: Note

References (64)

1. Arendt T., Brückner M.K., Gertz H.J., Marcova L. Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain. Neuroscience. 83:1998;991-1002.
2. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex. 1:1991;103-116.
3. Bachevalier J, Mishkin M. Ontogenetic development and decline of memory functions in nonhuman primates. In: Kostovic I, Knezevic S, Wisniewski HM, Spillich GJ, editors. Neurodevelopment, aging and cognition. Boston: Birkhäuser; 1992. p. 37-59.
4. Bartzokis G., Cummings J.L., Sultzer D., Henderson V., Nuechterlein K.H., Mintz J. White matter structural integrity in healthy aging adults and patients with Alzheimer's disease. Arch. Neurol. 60:2003;393-398.
5. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:1995;357-366.
6. Benowitz L.I., Perrone-Bizzozero N.I., Finklestein S.P., Bird E.D. Localization of the growth-associated phophoprotein GAP-43 (B-50, F1) in the human cerebral cortex. J. Neurosci. 9:1989;990-995.
7. Braak H. Architectonics of the human telencephalic cortex. Berlin: Springer; 1980.
8. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82:1991;239-259.
9. Braak H., Braak E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol. 92:1996;197-201.
10. Braak H., Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol. Aging. 18:1997;351-357.
11. Braak H, Braak E. Temporal sequence of Alzheimer's disease-related pathology. In: Peters A, Morrison JH, editors. Cerebral cortex, vol. 14. New York: Plenum Press; 1999. p. 475-512.
12. Braak H., Braak E. Pathoanatomy of Parkinson's disease. J. Neurol. 247(Suppl. 2):2000;3-10.
13. Braak H., de Vos R.A.I., Jansen E.N.H., Bratzke H., Braak E. Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog. Brain Res. 117:1998;267-285.
14. Braak H, Del Tredici K, Schultz C, Braak E. Vulnerability of select neuronal types to Alzheimer's disease. In: Khachaturian ZS, Mesulam MM, editors. Alzheimer's disease. A compendium of current theories. Ann NY Acad Sci 2000;924:53-61.
15. Braak H., Del Tredici K., Rüb U., de Vos R.A.I., Jansen Steur E.N.H., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging. 24:2003;197-210.
16. Braak H., Rüb U., Gai W.P., Del Tredici K. Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J. Neural. Transm. 110:2003;517-536.
17. Braak H, Del Tredici K, Braak E. Spectrum of pathology. In: Petersen R, editor. Mild cognitive impairment. New York: Oxford University Press; 2003. p. 149-89.
18. Brady S.T., Witt A.S., Kirkpatrick L.L., de Waegh S.M., Readhead C., Tu P.H.et al. Formation of compact myelin is required for maturation of the axonal cytoskeleton. J. Neurosci. 19:1999;7278-7288.
19. Brody B.A., Kinney H.C., Kloman A.S., Gilles F.H. Sequence of central nervous system myelination in human infancy. I. An autopsy study of myelination. J. Neuropathol. Exp. Neurol. 46:1987;283-301.
20. Buell S.J., Coleman P.D. Dendritic growth in the aged human brain and failure of growth in senile dementia. Science. 206:1979;854-856.
21. Cadelli D.S., Bandtlow C.E., Schwab M.E. Oligodendrocyte- and myelin-associated inhibitors of neurite outgrowth: their involvement in the lack of CNS regeneration. Exp. Neurol. 115:1992;189-192.
22. Conel JL. The brain structure of the newborn infant and consideration of the senile brain. The inter-relationship of mind and body. vol. XIX. Cambridge, MA: Harvard University Press, Association for Research in Nervous and Mental Health; 1939. p. 247-55.
23. Del Tredici K., Rüb U., de Vos R.A.I., Bohl J.R.E., Braak H. Where does Parkinson disease pathology begin in the brain? J. Neuropathol. Exp. Neurol. 61:2002;413-426.
24. Del Tredici K, Braak H. Idiopathic Parkinson's disease: staging an α-synucleinopathy with a predictable pathoanatomy. In: Kahle P, Haass C, editors. Molecular basis of Parkinson's disease. Georgetown, TX: Landes Bioscience; 2003 [in press].
25. Dickson D.W. Neurodegenerative diseases with cytoskeletal pathology: a biochemical classification. Ann. Neurol. 42:1997;541-544.
26. Dickson D.W. Tau and synuclein and their role in neuropathology. Brain Pathol. 9:1999;657-661.
27. Flechsig P. Anatomie des menschlichen Gehirns und Rückenmarks auf myelogenetischer Grundlage. Leipzig: Thieme; 1920.
28. German D.C., White C.L., Sparkman D.R. Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neuroscience. 21:1987;305-312.
29. Giasson BI, Galvin JE, Lee VMY, Trojanowski JQ. The cellular and molecular pathology of Parkinson's disease. In: Clark CM, Trojanowski JQ, editors. Neurodegenerative dementias: clinical features and pathological mechanisms. New York: McGraw Hill; 2000. p. 219-28.
30. Goedert M, Trojanowski JQ, Lee VMY. The neurofibrillary pathology of Alzheimer's disease. In: Rosenberg RN, editor. The molecular and genetic basis of neurological disease. 2nd ed. Boston: Butterworth-Heinemann; 1997. p. 613-27.
31. Goedert M, Spillantini MG. Tauopathies and α-synucleinopathies. In: Lee VMY, Trojanowski JQ, Buée L, Christen Y, editors. Fatal attractions: protein aggregates in neurodegenerative disorders. Berlin: Springer; 2000. p. 66-86.
32. Hardy R., Reynolds R. Neuron-oligodendroglial interactions during central nervous system development. J. Neurosci. Res. 36:1993;121-126.
33. Hasegawa M., Houdou S., Mito T., Takashima S., Asanuma K., Ohno T. Development of myelination in the human fetal and infant cerebrum: a myelin basic protein immunohistochemical study. Brain Dev. 14:1992;1-6.
34. Hof P.R., Cox K., Morrison J.H. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease. I. Superior frontal and inferior temporal cortex. J. Comp. Neurol. 301:1990;44-54.
35. Hof P.R., Cox K., Young W.G., Celio M.R., Rogers J., Morrison J.H. Parvalbumin-immunoreactive neurons in the neocortex are resistant to degeneration in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 50:1991;451-462.
36. Hof P.R., Nimchinsky E.A., Celio M.R., Bouras C., Morrison J.H. Calretinin-immunoreactive neocortical interneurons are unaffected in Alzheimer's disease. Neurosci. Lett. 152:1993;145-149.
37. Hyman B.T., Goméz-Isla T. Alzheimer's disease is a laminar, regional, and neural system specific disease, not a global brain disease. Neurobiol. Aging. 15:1994;353-354.
38. Jenner P. Oxidative stress in Parkinson's disease. Ann. Neurol. 53(Suppl. 3):2003;26-38.
39. Kapfhammer J.P., Schwab M.E. Inverse patterns of myelination and GAP-43 expression in the adult CNS: neurite growth inhibitors as regulators of neuronal plasticity. J. Comp. Neurol. 340:1994;194-206.
40. Kartje G.I., Schulz M.K., Lopez-Yunez A., Schnell L., Schwab M.E. Corticostriatal plasticity is restricted by myelin-associated neurite growth inhibitors in the adult rat. Ann. Neurol. 45:1999;778-786.
41. Kinney H.C., Brody B.A., Kloman A.S., Gilles F.H. Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J. Neuropathol. Exp. Neurol. 47:1988;217-234.
42. Lewis D.A., Campbell M.J., Terry R.D., Morrison J.H. Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J. Neurosci. 7:1987;1799-1808.
43. Masliah E., Mallory M., Hansen L., Alford M., DeTeresa R., Terry R. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease. Am. J. Pathol. 142:1993;871-882.
44. Moceri V.M., Kukull W.A., Emanuel I., van Belle G., Larson E.B. Early-life risk factors and the development of Alzheimer's disease. Neurology. 54:2000;415-420.
45. Morrison B.M., Hof P.R., Morrison J.H. Determinants of neuronal vulnerability in neurodegenerative diseases. Ann. Neurol. 44(Suppl. 1):1998;32-44.
46. Neve R.L., Finch E.A., Bird E.D., Benowitz L.I. Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain. Proc. Natl. Acad. Sci. U.S.A. 85:1988;3638-3642.
47. Nieuwenhuys R. The neocortex: an overview of its evolutionary development, structural organization and synaptology. Anat. Embryol. 190:1994;307-337.
48. Nieuwenhuys R. The greater limbic system, the emotional motor system and the brain. Prog. Brain Res. 107:1996;551-580.
49. Nieuwenhuys R. Structure and organization of fibre systems. In: Nieuwenhuys R, Ten Donkelaar HJ, Nicholson C, editors. The central nervous system of vertebrates, vol 1. Berlin: Springer; 1999. p. 113-57.
50. Olanow C.W. An introduction to the free radical hypothesis in Parkinson's disease. Ann. Neurol. 32:1992;2-9.
51. Rapoport S.I. Brain evolution and Alzheimer's disease. Rev. Neurol. (Paris). 144:1988;79-90.
52. Reisberg B, Pattschull-Furlan A, Franssen E, Sclan SG, Kluger A, Dingcong L, et al. Dementia of the Alzheimer type recapitulates ontogeny inversely on specific ordinal and temporal parameters. In: Kostovic I, Knezevic S, Wisniewski HM, Spillich GJ, editors. Neurodevelopment, aging and cognition. Boston: Birkhäuser; 1992. p. 345-69.
53. Rüb U., Del Tredici K., Schultz C., Ghebremedhin E., de Vos R.A.I., Jansen Steur E.et al. Parkinson's disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology. Neurobiol. Aging. 23:2002;245-254.
54. Sanides F. Functional architecture of motor and sensory cortices in primates in the light of a new concept of neocortex evolution. In: Noback C, Montagna W, editors. Advances in primatology, vol. 1. New York, NY: Meredith; 1970. p. 137-208.
55. Saper CB. Diffuse cortical projection systems: anatomical organization and role in cortical function. In: Plum F, editor. Handbook of physiology, vol. 5. The nervous system. Bethesda: Am Physiol Soc; 1987. p. 169-210.
56. Schwab M.E. Myelin-associated inhibitors of neurite growth and regeneration in the CNS. Trends Neurosci. 13:1990;452-456.
57. Takahashi H., Wakabayashi K. The cellular pathology of Parkinson's disease. Neuropathology. 21:2001;315-322.
58. Tang Y., Nyengaard J.R., Pakkenberg B., Gundersen H.J.G. Age-induced white matter changes in the human brain: a stereological investigation. Neurobiol. Aging. 18:1997;609-615.
59. Tolnay M., Probst A. Review: tau protein pathology in Alzheimer's disease and related disorders. Neuropathol. Appl. Neurobiol. 25:1999;171-187.
60. Trojanowski J.Q., Lee V.M.Y. "Fatal attractions" of proteins. A comprehensive hypothetical mechanism underlying Alzheimer's disease and other neurodegenerative disorders. Ann. N.Y. Acad. Sci. 924:2000;62-67.
61. van der Knaap M.S., Valk J., Bakker C.J., Schooneveld M., Faber J.A.J., Willemse J.et al. Myelination as an expression of the functional maturity of the brain. Dev. Med. Child Neurol. 33:1991;849-857.
62. van der Knaap MS, Valk J. Magnetic resonance of myelin, myelination, and myelin disorders. 2nd ed. Springer: Berlin; 1995.
63. Yakovlev PI, Lecours AR. The myelogenetic cycles of regional maturation of the brain. In: Minkowksi A, editor. Regional development of the brain in early life. Oxford: Blackwell; 1967. p. 3-70.
64. Zilles K. Cortex. In: Paxinos G, editor. The human nervous system. New York: Academic Press; 1990. p. 757-802.